Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

10 The Company Das Unternehmen
The biolitec share – which is listed in the GEX® Index (like every owner-managed company which is
listed in the Prime Standard with an initial public offer within the last ten years) – mostly developed better
than the Prime Pharma & Healthcare Index during the last fiscal year and was able to perform again
from the middle of May after below-average performance in comparison to the index.
Share Price Development Chart 2009 - 2010 / Kursentwicklung